CD79A and influenza: This suggests that the combined enhancement of cell mediated (IgG2a) and humoral (IgA) responses may be ideal for a cooperative effect in providing clearance and protection not only against influenza infections, but also possibly other respiratory pathogens, indicating its potential as an adjuvant for mucosal vaccines.